glp-1 effect on insulin Receptor Agonists as Treatments for Type 2 Diabetes GLP-1 receptor signalling promotes β-cell

Critical Quality Attributes (CQAs): The target particle size for optimal absorption must stay between 80nm and 200nm to ensure the vesicles move through the gut wall effectively

BioFusion checks stereochemistry by chiral HPLC at every release

Improved Skin Elasticity and Firmness: Restoring the skins structural integrity leads to firmer, more resilient skin

Ubiquitination in melanoma pathogenesis and treatment

Englund A, Lange AH, Hagemann CA, et al

This new trial built on a previous one published in NEJM last fall (I previously reviewed here) for the same indication, but the only difference was the inclusion of people with diabetes